EP1853265
FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.1.2006EP published:
27.1.2016EP application number:
06733984.6
EPO information:
European Patent Register
Max expiry date:
26.1.2026
Title:
FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS
Timeline
Today
27.1.2006EP application
27.1.2016EP Publication
Owner
Name:
The Government of the United States of America as represented by the Secretary of the Department of Health and Human ServicesAddress:
National Institutes of Health, Suite 325, 6011 Executive Boulevard, 20852-3804, Rockville, MD, US
Name:
The Progeria Research Foundation, Inc.Address:
P.O. Box 3453, 01961-3453, Peabody, MA, US
Name:
THE REGENTS OF THE UNIVERSITY OF MICHIGANAddress:
Wolverine Tower Room 2071, 3003 South State Street, 48109-1290, Ann Arbor,Michigan, US
Name:
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLAddress:
Office of Technology Development, Campus Box 4105, 308 Bynum Hall, 27599-4105, Chapel Hill, NC, US
Inventor
Name:
GORDON, Leslie, B.Address:
Foxboro, MA, US
Name:
COLLINS, Francis, S.Address:
Rockville, MD, US
Name:
GLOVER, ThomasAddress:
Ypsilanti, MI, US
Name:
GLYNN, Michael, W.Address:
Darien, CT, US
Name:
CAPELL, Brian, C.Address:
Rumson, NJ, US
Name:
COX, Adrienne, D.,c/o Dept. Radiation OncologyAddress:
Chapel Hill, NC, US
Name:
DER, Channing, J.,c/o Lineberger Comp.Cancer Ctr.Address:
Chapel Hill, NC, US
Priority
Number:
648307 PDate:
28.1.2005Country:
US
Number:
707192 PDate:
9.8.2005Country:
US
Classification
Categories:
A61K 31/4704, A61K 31/221, A61K 31/255, A61K 31/445, A61K 31/473, A61P 43/00